| Code | Description | Claims | Beneficiaries | Total Paid |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
19,027 |
17,274 |
$2.03M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
22,800 |
19,108 |
$1.57M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
10,612 |
8,103 |
$660K |
| 80053 |
Comprehensive metabolic panel |
16,029 |
11,914 |
$606K |
| 70450 |
Computed tomography, head or brain; without contrast material |
5,639 |
4,294 |
$402K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
2,927 |
2,434 |
$335K |
| 36415 |
Collection of venous blood by venipuncture |
28,440 |
18,590 |
$318K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
5,804 |
5,446 |
$273K |
| 76819 |
Fetal biophysical profile; without non-stress testing |
2,403 |
1,325 |
$257K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
4,868 |
3,871 |
$195K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
3,174 |
2,665 |
$159K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
1,672 |
1,526 |
$140K |
| J7050 |
Infusion, normal saline solution, 250 cc |
1,139 |
698 |
$137K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
3,044 |
2,259 |
$136K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
4,235 |
1,713 |
$135K |
| 59025 |
Fetal non-stress test |
2,454 |
1,168 |
$122K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
1,382 |
1,124 |
$112K |
| G0378 |
Hospital observation service, per hour |
12,025 |
4,950 |
$110K |
| 81003 |
|
13,932 |
11,435 |
$104K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
1,277 |
330 |
$102K |
| 82948 |
|
9,510 |
2,851 |
$98K |
| 59899 |
|
2,671 |
1,951 |
$86K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
4,941 |
3,350 |
$73K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
1,573 |
390 |
$70K |
| 87631 |
|
1,348 |
1,256 |
$57K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
29,926 |
22,363 |
$54K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
4,026 |
3,320 |
$46K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
2,903 |
2,368 |
$44K |
| 80047 |
|
9,199 |
7,317 |
$36K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
1,576 |
1,242 |
$35K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
524 |
421 |
$32K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
875 |
719 |
$31K |
| 84484 |
|
11,134 |
6,155 |
$28K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
1,268 |
1,144 |
$24K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
200 |
170 |
$22K |
| 71046 |
Radiologic examination, chest; 2 views |
2,196 |
1,860 |
$20K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
533 |
357 |
$19K |
| 71045 |
Radiologic examination, chest; single view |
8,861 |
6,888 |
$18K |
| 84702 |
|
1,132 |
884 |
$18K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
13,107 |
9,816 |
$18K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
1,293 |
1,116 |
$18K |
| 84112 |
|
58 |
51 |
$17K |
| G0399 |
Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation |
279 |
248 |
$17K |
| 87480 |
|
935 |
831 |
$17K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
556 |
508 |
$17K |
| 81025 |
|
781 |
694 |
$16K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
175 |
65 |
$15K |
| 85610 |
|
4,883 |
3,517 |
$15K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
439 |
395 |
$15K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
2,471 |
1,934 |
$15K |
| 74018 |
|
1,151 |
992 |
$14K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
2,010 |
1,594 |
$13K |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
37 |
28 |
$12K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
8,413 |
6,060 |
$10K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
1,762 |
1,602 |
$10K |
| 83735 |
|
4,497 |
2,934 |
$9K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
143 |
108 |
$8K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
1,614 |
1,115 |
$8K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
573 |
526 |
$7K |
| 96367 |
|
267 |
116 |
$6K |
| A9270 |
Non-covered item or service |
3,385 |
1,234 |
$6K |
| 85027 |
|
2,616 |
1,738 |
$6K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
354 |
316 |
$6K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
828 |
600 |
$6K |
| 83880 |
|
4,933 |
3,585 |
$6K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
668 |
592 |
$5K |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
2,307 |
1,868 |
$5K |
| 82330 |
|
7,809 |
6,162 |
$5K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
972 |
804 |
$5K |
| 72100 |
|
587 |
414 |
$5K |
| 70486 |
|
58 |
48 |
$5K |
| 73610 |
|
208 |
180 |
$4K |
| 85730 |
|
1,362 |
1,039 |
$4K |
| 93971 |
|
310 |
249 |
$4K |
| 95811 |
|
14 |
13 |
$4K |
| J3490 |
Unclassified drugs |
156 |
133 |
$4K |
| C1769 |
Guide wire |
493 |
335 |
$4K |
| 84156 |
|
601 |
367 |
$4K |
| 73562 |
|
545 |
374 |
$4K |
| 73030 |
|
202 |
160 |
$4K |
| 87070 |
|
220 |
178 |
$4K |
| 73630 |
|
275 |
239 |
$4K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
3,297 |
2,283 |
$4K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
52 |
45 |
$4K |
| 0100U |
|
273 |
241 |
$3K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
42 |
36 |
$3K |
| C1729 |
Catheter, drainage |
43 |
24 |
$3K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
99 |
80 |
$3K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
1,648 |
1,115 |
$3K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
148 |
123 |
$3K |
| 97162 |
|
124 |
104 |
$3K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
2,327 |
1,833 |
$3K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
3,067 |
2,415 |
$3K |
| 84703 |
|
5,082 |
4,400 |
$3K |
| 84145 |
|
1,960 |
1,482 |
$3K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
3,970 |
3,130 |
$3K |
| 83690 |
|
4,944 |
4,007 |
$3K |
| 76830 |
Ultrasound, transvaginal |
360 |
322 |
$2K |
| 76801 |
|
853 |
710 |
$2K |
| 87040 |
|
2,612 |
2,087 |
$2K |
| 84100 |
|
461 |
298 |
$2K |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,061 |
846 |
$2K |
| 83605 |
|
2,171 |
1,641 |
$2K |
| J1815 |
Injection, insulin, per 5 units |
977 |
425 |
$2K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
42 |
36 |
$2K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
489 |
294 |
$2K |
| 85380 |
|
939 |
809 |
$2K |
| 81001 |
|
450 |
383 |
$1K |
| 80061 |
Lipid panel |
1,018 |
762 |
$1K |
| 72040 |
|
15 |
13 |
$1K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
106 |
92 |
$1K |
| 86850 |
|
1,303 |
1,040 |
$1K |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
60 |
47 |
$1K |
| 76770 |
|
32 |
27 |
$1K |
| 87186 |
|
1,280 |
1,010 |
$851.54 |
| 87641 |
|
254 |
180 |
$806.75 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
122 |
89 |
$793.82 |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
55 |
48 |
$793.82 |
| 97161 |
|
17 |
16 |
$785.72 |
| 86900 |
|
1,471 |
1,192 |
$777.87 |
| 73080 |
|
17 |
15 |
$754.55 |
| 93970 |
|
29 |
24 |
$737.79 |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
18 |
15 |
$736.87 |
| 87077 |
|
1,582 |
1,267 |
$730.43 |
| 86140 |
|
1,462 |
1,222 |
$697.13 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
336 |
221 |
$696.32 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
1,336 |
989 |
$696.08 |
| 77066 |
Tomosynthesis, mammo |
13 |
12 |
$567.88 |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
48 |
37 |
$536.71 |
| 73130 |
|
53 |
42 |
$535.41 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
2,065 |
1,249 |
$511.48 |
| 36591 |
|
72 |
45 |
$395.77 |
| 87205 |
|
368 |
293 |
$340.25 |
| A9585 |
Injection, gadobutrol, 0.1 ml |
172 |
138 |
$319.58 |
| 73110 |
|
14 |
13 |
$297.12 |
| J2060 |
Injection, lorazepam, 2 mg |
972 |
704 |
$258.21 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
678 |
551 |
$252.13 |
| 82077 |
|
62 |
51 |
$249.50 |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
30 |
26 |
$231.10 |
| 80076 |
|
115 |
101 |
$227.79 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
668 |
593 |
$209.04 |
| 82550 |
|
357 |
287 |
$146.96 |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
559 |
510 |
$139.56 |
| 87581 |
|
557 |
508 |
$139.56 |
| 87486 |
|
557 |
508 |
$139.56 |
| 87660 |
|
922 |
821 |
$113.08 |
| 86901 |
|
1,474 |
1,191 |
$103.76 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
106 |
53 |
$92.57 |
| 87510 |
|
921 |
820 |
$90.66 |
| 85652 |
|
648 |
541 |
$88.76 |
| G8978 |
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals |
16 |
13 |
$61.15 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
929 |
737 |
$48.11 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
262 |
112 |
$42.90 |
| 82570 |
|
277 |
210 |
$37.35 |
| 72050 |
|
21 |
12 |
$37.31 |
| 87400 |
|
21 |
15 |
$30.96 |
| 82607 |
|
14 |
12 |
$11.72 |
| 84550 |
|
64 |
51 |
$8.44 |
| J7510 |
Prednisolone oral, per 5 mg |
91 |
72 |
$0.00 |
| 96417 |
|
19 |
12 |
$0.00 |
| 82805 |
|
51 |
38 |
$0.00 |
| 29125 |
|
69 |
63 |
$0.00 |
| 90715 |
|
31 |
27 |
$0.00 |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
19 |
13 |
$0.00 |
| C9113 |
Injection, pantoprazole sodium, per vial |
76 |
50 |
$0.00 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
128 |
100 |
$0.00 |
| 12011 |
|
16 |
13 |
$0.00 |
| J0692 |
Injection, cefepime hydrochloride, 500 mg |
20 |
12 |
$0.00 |
| 87506 |
|
13 |
13 |
$0.00 |
| J8540 |
Dexamethasone, oral, 0.25 mg |
52 |
36 |
$0.00 |
| 87640 |
|
14 |
13 |
$0.00 |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
48 |
42 |
$0.00 |
| 83615 |
|
43 |
30 |
$0.00 |
| 82728 |
|
125 |
85 |
$0.00 |
| 72072 |
|
13 |
12 |
$0.00 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
17 |
14 |
$0.00 |
| 86308 |
|
29 |
25 |
$0.00 |
| 88342 |
|
13 |
12 |
$0.00 |
| 72170 |
|
16 |
13 |
$0.00 |
| 90686 |
|
25 |
15 |
$0.00 |